NCT00598858View on ClinicalTrials.gov

Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Prostate CancerAdenocarcinoma of the ProstateStage I Prostate CancerStage II Prostate Cancer
Interventions
DRUG

Docetaxel

Given IV

DRUG

Prednisone

Given PO

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

John P. Fruehauf

OTHER